Citation: Ml. Giron et al., AN EVOLUTIONARILY CONSERVED SPLICE GENERATES A SECRETED ENV-BET FUSION PROTEIN DURING HUMAN FOAMY VIRUS-INFECTION, Journal of virology, 72(6), 1998, pp. 4906-4910
Authors:
CHELBIALIX MK
QUIGNON F
PELICANO L
KOKEN MHM
DETHE H
Citation: Mk. Chelbialix et al., RESISTANCE TO VIRUS-INFECTION CONFERRED BY THE INTERFERON-INDUCED PROMYELOCYTIC LEUKEMIA PROTEIN, Journal of virology, 72(2), 1998, pp. 1043-1051
Authors:
GIANNI M
KOKEN MHM
CHELBIALIX MK
BENOIT G
LANOTTE M
CHEN Z
DETHE H
Citation: M. Gianni et al., COMBINED ARSENIC AND RETINOIC ACID TREATMENT ENHANCES DIFFERENTIATIONAND APOPTOSIS IN ARSENIC-RESISTANT NB4 CELLS, Blood, 91(11), 1998, pp. 4300-4310
Citation: H. Dethe, ARSENIC AND RETINOIC ACID, TOWARDS ONCOGE NE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA, Bulletin de l'Academie nationale de medecine, 182(1), 1998, pp. 63-71
Citation: H. Dethe, ARSENIC TRIOXIDE - AFTER RETINOIC ACID, A NEW ONCOGENE TARGETED TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA, MS. Medecine sciences, 13(6-7), 1997, pp. 867-871
Citation: F. Quignon et al., RETINOIC ACID AND ARSENIC - TOWARDS ONCOGENE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA, Biochimica et biophysica acta, CR. Reviews on cancer, 1333(3), 1997, pp. 53-61
Authors:
DETHE H
ZHU J
KOKEN M
QUIGNON F
CHEN Z
DEGOS L
Citation: H. Dethe et al., ARSENIC AND RETINOIC ACID - TOWARDS RATIONAL TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA, Experimental hematology, 25(8), 1997, pp. 633-633
Authors:
ZHU J
KOKEN MHM
QUIGNON F
CHELBIALIX MK
DEGOS L
WANG ZY
CHEN Z
DETHE H
Citation: J. Zhu et al., ARSENIC-INDUCED PML TARGETING ONTO NUCLEAR-BODIES - IMPLICATIONS FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3978-3983
Authors:
KOKEN MHM
REID A
QUIGNON F
CHELBIALIX MK
DAVIES JM
KABAROWSKI JHS
ZHU J
DONG S
CHEN SJ
CHEN Z
TAN CC
LICHT J
WAXMAN S
DETHE H
ZELENT A
Citation: Mhm. Koken et al., LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES, Proceedings of the National Academy of Sciences of the United Statesof America, 94(19), 1997, pp. 10255-10260
Authors:
SAIB A
PUVIONDUTILLEUL F
SCHMID M
PERIES J
DETHE H
Citation: A. Saib et al., NUCLEAR TARGETING OF INCOMING HUMAN FOAMY VIRUS GAG PROTEINS INVOLVESA CENTRIOLAR STEP, Journal of virology, 71(2), 1997, pp. 1155-1161
Authors:
BAZARBACHI A
SORIANO V
PAWSON R
VALLEJO A
MOUDGIL T
MATUTES E
PERIES J
MOLINA A
DETHE H
SCHULZ TF
CATOVSKY D
GILL PS
Citation: A. Bazarbachi et al., MYCOSIS-FUNGOIDES AND SEZARY-SYNDROME ARE NOT ASSOCIATED WITH HTLV-I INFECTION - AN INTERNATIONAL STUDY, British Journal of Haematology, 98(4), 1997, pp. 927-933
Authors:
CHEN GQ
SHI XG
TANG W
XIONG SM
ZHU J
CAI X
HAN ZG
NI JH
SHI GY
JIA PM
LIU MM
HE KL
NIU C
MA J
ZHANG P
ZHANG TD
PAUL P
NAOE T
KITAMURA K
MILLER W
WAXMAN S
WANG ZY
DETHE H
CHEN SJ
CHEN Z
Citation: Gq. Chen et al., USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS, Blood, 89(9), 1997, pp. 3345-3353
Citation: A. Saib et H. Dethe, MOLECULAR-BIOLOGY OF THE HUMAN FOAMY VIRUS, Journal of acquired immune deficiency syndromes and human retrovirology, 13, 1996, pp. 254-260
Authors:
GRANDE MA
VANDERKRAAN I
VANSTEENSEL B
SCHUL W
DETHE H
VANDERVOORT HTM
DEJONG L
VANDRIEL R
Citation: Ma. Grande et al., PML-CONTAINING NUCLEAR-BODIES - THEIR SPATIAL-DISTRIBUTION IN RELATION TO OTHER NUCLEAR-COMPONENTS, Journal of cellular biochemistry, 63(3), 1996, pp. 280-291
Authors:
SZEKELY L
POKROVSKAJA K
JIANG WQ
DETHE H
RINGERTZ N
KLEIN G
Citation: L. Szekely et al., THE EPSTEIN-BARR VIRUS-ENCODED NUCLEAR ANTIGEN EBNA-5 ACCUMULATES IN PML-CONTAINING BODIES, Journal of virology, 70(4), 1996, pp. 2562-2568
Authors:
ANDRE C
GUILLEMIN MC
ZHU J
KOKEN MHM
QUIGNON F
HERVE L
CHELBIALIX MK
DHUMEAUX D
WANG ZY
DEGOS L
CHEN Z
DETHE H
Citation: C. Andre et al., THE PML AND PML RAR-ALPHA DOMAINS - FROM AUTOIMMUNITY TO MOLECULAR ONCOLOGY AND FROM RETINOIC ACID TO ARSENIC/, Experimental cell research, 229(2), 1996, pp. 253-260
Authors:
DENT AL
YEWDELL J
PUVIONDUTILLEUL F
KOKEN MHM
DETHE H
STAUDT LM
Citation: Al. Dent et al., LYSP100-ASSOCIATED NUCLEAR DOMAINS (LANDS) - DESCRIPTION OF A NEW CLASS OF SUBNUCLEAR STRUCTURES AND THEIR RELATIONSHIP TO PML NUCLEAR-BODIES, Blood, 88(4), 1996, pp. 1423-1436
Authors:
KOKEN M
REID A
QUIGNON F
DONG S
CHEN Z
STRUTT P
LICHT J
WAXMAN S
DETHE H
ZELENT A
Citation: M. Koken et al., PRODUCTS OF THE PML AND PLZF GENES TRANSLOCATED WITH THE RAR-ALPHA LOCUS IN ACUTE PROMYELOCYTIC LEUKEMIA CO-LOCALIZE IN THE NUCLEUS AND INTERACT WITH EACH OTHER IN-VIVO, Blood, 88(10), 1996, pp. 2202-2202
Authors:
GUIOCHONMANTEL A
SAVOURET JF
QUIGNON F
DELABRE K
MILGROM E
DETHE H
Citation: A. Guiochonmantel et al., EFFECT OF PML AND PML-RAR ON THE TRANSACT IVATION PROPERTIES AND SUBCELLULAR-DISTRIBUTION OF STEROID-HORMONE RECEPTORS, Annales d'Endocrinologie, 57(2), 1996, pp. 91-100
Authors:
BAZARBACHI A
SORIANO V
VALLEJO A
MOUDGIL T
MOLINA A
SAAL F
PERIES J
DETHE H
GILL PS
Citation: A. Bazarbachi et al., MYCOSIS-FUNGOIDES AND SEZARY-SYNDROME ARE NOT ASSOCIATED WITH HTLV-I INFECTION - AN INTERNATIONAL STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 96-96
Citation: A. Saib et H. Dethe, MOLECULAR-BASIS OF CHRONIC INFECTIONS BY SPUMARETROVIRUSES, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 238-238